2025-11-06 - Analysis Report
Okay, here's a report analyzing Tempus AI Inc. (TEM) based on the data you provided, following your requested format:

## Tempus AI Inc. (TEM) Stock Analysis

**Company Overview:** Tempus AI Inc. is a technology company focused on precision medicine through data and artificial intelligence.

### 1. Performance vs. S&P 500 (VOO)

*   **TEM Cumulative Return:** 40.17%
*   **VOO Cumulative Return:** 28.74%
*   **Absolute Divergence:** 11.3%
*   **Relative Divergence:** 45.1 (Indicates that TEM's relative performance is in the 45.1 percentile based on historical range.)
    This means that TEM's return has outperformed VOO, placing its outperformance in the middle range of its historical performance relative to the S&P 500.

**Alpha/Beta Analysis:**

| Year       | CAGR   | MDD   | Alpha  | Beta | Cap(B) |
|------------|--------|-------|--------|------|--------|
| 2023-2025  | 40.0%  | 76.7% | 12.0%  | 0.3  | 14.3   |

**Analysis:** The provided data suggests high growth potential (40% CAGR) but also significant volatility (76.7% MDD). The Alpha of 12% indicates outperformance relative to the market, and the Beta of 0.3 suggests low sensitivity to overall market movements. The large market capitalization ($14.3B) suggests a substantial company.

### 2. Recent Stock Price Movement

*   **Current Price:** 82.169
*   **Last Market Data:** {'price': 82.24, 'previousClose': 84.49, 'change': -2.66}
*   **5-Day Moving Average:** 87.1678
*   **20-Day Moving Average:** 90.5972
*   **60-Day Moving Average:** 83.7952

**Analysis:** The stock is currently trading below its 5-day and 20-day moving averages, suggesting a short-term downtrend. However, it's slightly below its 60-day moving average, suggesting potential support around that level. The recent price change of -2.66 indicates downward pressure.

### 3. Technical Indicators and Outlook

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended)
*   **RSI:** 37.52 (Approaching oversold territory)
*   **PPO:** -1.17 (Negative, suggesting a downtrend)
*   **Hybrid Signal:** Sell 79.9% of holdings (Cash Ratio: 79% on 2025-10-16).
*   **20-Day Relative Divergence Change:** -4.4 (Indicates a recent decrease in relative outperformance)
*   **Expected Return (%):** NaN

**Analysis:** The MRI suggests high investment is recommended, which is in contrast to the sell signal.
The RSI is approaching the oversold region, implying that the stock may be due for a rebound. The negative PPO reinforces the indication of a downtrend. The negative change in relative divergence points to weakening performance. The 'NaN' expected return suggests that the data to calculate the return isn't available.
**The recent price decrease (-2.66 from previous close) amplifies the signal that there is a short-term volatility.**

### 4. Recent News & Significant Events

*   **Positive Headlines:** Several news articles highlight Tempus AI's strong genomics growth, Q3 2025 earnings performance (revenue exceeding expectations), and acceptance of abstracts at a major conference. Recent healthcare partnerships also signal potential upside.
*   **Mixed Headlines:** Some articles focus on Q3 losses, even while acknowledging revenue beats.

**Analysis:** Recent news flow is mixed but leans positive, emphasizing growth and strategic partnerships. The market seems to be reacting to the losses, but there's underlying positive sentiment regarding the company's potential.

### 4-2. Analyst Opinions

*   **Consensus:** Buy (Mean: 2.21)
*   **Number of Opinions:** 12
*   **Target Price:**
    *   Average: 87.08
    *   High: 110.00
    *   Low: 60.00

**Analysis:** Analyst consensus is generally positive, with a "Buy" rating. The average target price is higher than the current price, suggesting potential upside.

### 5. Recent Earnings Analysis

| Date       | EPS   | Expected EPS |
|------------|-------|--------------|
| 2025-11-04 | -0.11 | -0.16        |
| 2025-08-08 | -0.22 | -0.22988     |
| 2025-05-06 | -0.24 | -0.26003     |
| 2025-02-24 | -0.18 | -0.15        |
| 2024-11-04 | -0.25 | -0.26608     |

**Analysis:** Tempus AI has consistently reported losses per share (EPS). However, in most recent quarters, the company has beaten EPS expectations. The recent report shows a loss of -0.11 EPS versus an expected -0.16. This trend of beating expectations is a positive sign.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue | Profit Margin |
|------------|---------|---------------|
| 2025-06-30 | $0.31B  | 61.99%        |
| 2025-03-31 | $0.26B  | 60.69%        |
| 2024-12-31 | $0.20B  | 60.83%        |
| 2024-09-30 | $0.18B  | 58.50%        |
| 2024-06-30 | $0.17B  | 45.50%        |

**Capital and Profitability:**

| Quarter    | Equity  | ROE       |
|------------|---------|-----------|
| 2025-06-30 | $0.31B  | -13.84%   |
| 2025-03-31 | $0.33B  | -20.86%   |
| 2024-12-31 | $0.06B  | -23.10%   |
| 2024-09-30 | $0.05B  | -141.16%  |
| 2024-06-30 | $0.10B  | -562.04%  |

**Analysis:**

*   **Revenue Growth:** Revenue is showing strong growth, increasing from $0.17B in Q2 2024 to $0.31B in Q2 2025.
*   **High Profit Margins:** The company maintains high profit margins, generally above 60%.
*   **Negative ROE:** Return on Equity (ROE) is negative, indicating that the company is not generating profits from its equity base.

### 7. Overall Assessment

Tempus AI presents a mixed picture.

*   **Positives:**
    *   Strong revenue growth and high profit margins.
    *   Positive analyst ratings with potential upside based on target prices.
    *   Recent news flow, highlighting growth and strategic partnerships.
    *   High Market Risk Indicator (MRI) implying investment is recommended.
*   **Negatives:**
    *   Consistent losses per share (EPS) and negative ROE.
    *   Technical indicators suggesting a short-term downtrend.
    *   High historical volatility (MDD).
    *   Sell signal given by hybrid signal analysis.

**Conclusion:**

The data suggests Tempus AI is a high-growth company with strong revenue and a good growth rate, but it is not yet profitable. Investors should weigh the potential for future profitability against the current losses and the stock's volatility. The recent price decrease and the mixed technical signals suggest caution in the short term. However, the positive analyst ratings and strong revenue growth indicate long-term potential. The MRI suggests a good investment, while the hybrid signal recommends a sell, highlighting the conflicting information that must be weighed by investors.
